News Featured July 2, 2026 Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services July 2, 2026 Read more → July 2, 2026 June 16, 2026 Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test June 16, 2026 Read more → June 16, 2026 June 11, 2026 Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection June 11, 2026 Read more → June 11, 2026 May 27, 2026 Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer May 27, 2026 Read more → May 27, 2026 April 15, 2026 Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors April 15, 2026 Read more → April 15, 2026 February 26, 2026 Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma February 26, 2026 Read more → February 26, 2026 January 8, 2026 Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care January 8, 2026 Read more → January 8, 2026 December 4, 2025 Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma December 4, 2025 Read more → December 4, 2025 November 13, 2025 Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025 November 13, 2025 Read more → November 13, 2025 November 6, 2025 Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year” November 6, 2025 Read more → November 6, 2025 October 15, 2025 Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases October 15, 2025 Read more → October 15, 2025 September 3, 2025 Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas September 3, 2025 Read more → September 3, 2025 June 17, 2025 Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing June 17, 2025 Read more → June 17, 2025 April 10, 2025 New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests April 10, 2025 Read more → April 10, 2025
